Early lab studies show that a COVID-19 antibody treatment developed by GlaxoSmithKline and Vir Biotechnology could be effective against the Omicron variant.
The companies said Thursday that they tested the drug, called sotrovimab, against individual mutations found in the Omicron variant, accordingThe preliminary findings haven’t yet been peer-reviewed, and the drug will need to be tested against the whole spikeGlaxoSmithKline and Vir have previously tested sotrovimab against mutations on other variants, the newspaper reported.
GlaxoSmithKline expects to see results from testing the drug against the full mutated spike protein in the next 2 to 3 weeks, theSotrovimab has been authorized in about a dozen countries, including the U.S., which paid about $1 billion for hundreds of thousands of doses.
Another experimental antibody therapy developed by Adagio Therapeutics appears to work well against the new variant, theAntiviral drugs could also help prevent hospitalization and may be less vulnerable to new variants because they target a different part of the virus, the newspaper reported. Merck and Pfizer have developed antiviral pills, which still require FDA approval.
In addition, Gilead believes its approved IV therapy, called remdesivir, will continue to be effective against the variant, Reuters reported.can have on Omicron and expects to have more information in coming weeks, Reuters reported.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
First Omicron Covid-19 Case Confirmed in U.S., CDC SaysThe CDC has confirmed a person in California has contracted the Omicron Covid-19 variant, but reportedly only suffered mild symptoms and is improving.
続きを読む »
Do Current COVID-19 Tests Still Detect Omicron?Here’s how the current COVID-19 tests, whether they’re done by a lab or at-home, work against the latest variant
続きを読む »
S.Korea hits new COVID-19 record, halts quarantine exemptions to block OmicronSouth Korea's daily coronavirus case numbers rose to a new high on Thursday, as authorities halted quarantine exemptions for fully vaccinated inbound travellers for two weeks in a bid to fend off the Omicron variant.
続きを読む »
First confirmed US case of the omicron variant detected in California: COVID-19 updatesThe California and San Francisco Departments of Public Health confirmed that a recent case of COVID-19 found on an individual in the city was caused by omicron. The person was a traveler who returned from South Africa on Nov. 22 and was fully vaccinated.
続きを読む »
Glaxo’s Covid-19 Antibody Drug Found to Be Effective Against OmicronThe antibody treatment was effective against the variant in early laboratory studies, setting it apart from similar therapies that appear to work less well against the highly mutated strain.
続きを読む »
Did a collision of COVID-19 and HIV forge the Omicron variant?The Omicron variant was probably incubated in a person with poorly controlled HIV who struggled to clear a coronavirus infection.
続きを読む »